-
Review of Trends in Molecular Medicine by Zhou Rongbin/Huang Yi team: Inflammasome and HIV-1 infection and treatment
Time of Update: 2022-06-08
This paper comprehensively and systematically summarizes the role and mechanism of the inflammasome and its mediated pyroptosis in HIV-1 infection and treatment, and discusses the possibility of the inflammasome as a therapeutic target for HIV-1-related diseases .
-
Innovent Announces Preliminary Results of a Phase I Clinical Study of IBI322 (PD-L1/CD47 Bispecific Antibody) at the 2022 AACR Annual Meeting in Subjects with Advanced Malignancies who Failed Standard
Time of Update: 2022-05-24
<> /* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prne
-
New treatment for breast cancer with fewer side effects
Time of Update: 2021-08-26
A randomized phase II study of PREDIX HER2 was conducted in 9 Swedish cinics, with the purpose of investigating its efficacy (proportion of complete response after treatment) with neoadjuvant therapy) and the frequency and degree of side effects .
-
Jimin trusted new crown and antibody initiated Phase 1 clinical
Time of Update: 2021-01-25
JMB2002 is an all-human-specific neutral antibody developed by Jimin Trust Group Shanghai Research Institute, which is intended to be used to prevent and treat new coronavirus infections.
-
Effect of Helicobacter Pylori Eradication on Rebleeding of Duodenal Ulcer
Time of Update: 2021-01-25
2 Results gastric glasses confirmed that there was no significant difference in ulcer healing rates between the two groups of patients 4 weeks after the end of treatment.
We believe that hp-positive patients with hemorrhage of duoon ulcers should actively eradicate Hp treatment in order to reduce ulcer recurrence or re-bleeding.
-
Cell Metabolism: Breakthrough! For the first time, teams such as Li Hongliang of Wuhan University have solved the global problem of new coronary drug treatment for glucodermal hormone therapy, which
Time of Update: 2021-01-13
On January 5, 2021, Wuhan University, Central South University, UCLA and other multi-unit cooperation, Li Hongliang, Zhang Xiaojing, Yang Wei and Zhang Xin and other common communications published online in Cell Metabolism entitled "The neutrophil-to- A research paper by lymphocyte ratio decisions clinical efficacy of corticosteroid therapy in patients with COVID-19" is the first global study to clarify the boundaries of glucosticoids ("hormones") in the treatment of neocoopnetis.
-
AstraZeneia's COVID-19 vaccine is expected to receive provisional approval in the UK for a planned new half-dose trial
Time of Update: 2020-12-11
like Pfizer and Moderna, AstraZeneta announced earlier this week that the positive results of its COVID-19 vaccine trial were as effective as 90 percent and that patients did not experience any serious side effects after vaccination.
-
Titibiev can effectively treat hepatitis B
Time of Update: 2020-07-04
two recent studies published by the University of Hong Kong and the University of Chinese of Hong Kong show that the new drug for the treatment of hepatitis B is more effective at suppressing the vi
-
The medicinal value and function of Ganoderma lucidum
Time of Update: 2020-04-03
Ganoderma lucidum, a mushroom like herb, contains powerful bioremediation factors, so it is very good for your health Whether it is to treat or prevent diseases, Ganoderma lucidum can be used as an ef
-
Scientists have discovered a new potential therapy for malignant pancreatic cancer
Time of Update: 2019-08-09
Recently, scientists from Curtin University of science and technology in Australia have found a new potential therapy for the treatment of malignant pancreatic cancer, which is expected to increase th
-
The limit of adjuvant is coming! Is there time for self-help of traditional Chinese medicine injection
Time of Update: 2019-04-23
In February 2019, the focus interview on the news reported on the catalogue of auxiliary drugs was regarded by the industry as the early warming up of the national edition of the catalogue of auxiliar
